BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11466615)

  • 1. Healthy mice with an altered c-myc gene: role of the 3' untranslated region revisited.
    Langa F; Lafon I; Vandormael-Pournin S; Vidaud M; Babinet C; Morello D
    Oncogene; 2001 Jul; 20(32):4344-53. PubMed ID: 11466615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aberrant regulation of mRNA 3' untranslated region in cancers and inflammation].
    Nguyen-Chi M; Morello D
    Med Sci (Paris); 2008 Mar; 24(3):290-6. PubMed ID: 18334178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5' and 3' non-coding sequences of the c-myc gene, required in vitro for its post-transcriptional regulation, are dispensable in vivo.
    Morello D; Lavenu A; Pournin S; Babinet C
    Oncogene; 1993 Jul; 8(7):1921-9. PubMed ID: 8510935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of protein expression through mRNA stability in calcium signalling.
    Misquitta CM; Chen T; Grover AK
    Cell Calcium; 2006 Oct; 40(4):329-46. PubMed ID: 16765440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
    Mazure NM; Chauvet C; Bois-Joyeux B; Bernard MA; Nacer-Chérif H; Danan JL
    Cancer Res; 2002 Feb; 62(4):1158-65. PubMed ID: 11861398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA.
    Mickleburgh I; Burtle B; Hollås H; Campbell G; Chrzanowska-Lightowlers Z; Vedeler A; Hesketh J
    FEBS J; 2005 Jan; 272(2):413-21. PubMed ID: 15654879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant translational control of the c-myc gene in multiple myeloma.
    Paulin FE; West MJ; Sullivan NF; Whitney RL; Lyne L; Willis AE
    Oncogene; 1996 Aug; 13(3):505-13. PubMed ID: 8760292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 expression is strongly repressed by AU-rich elements in the 3'-untranslated region of the gene.
    Reimunde FM; Castañares C; Redondo-Horcajo M; Lamas S; Rodríguez-Pascual F
    Biochem J; 2005 May; 387(Pt 3):763-72. PubMed ID: 15595926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What determines the instability of c-myc proto-oncogene mRNA?
    Laird-Offringa IA
    Bioessays; 1992 Feb; 14(2):119-24. PubMed ID: 1575711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.
    Chepko G; Slack R; Carbott D; Khan S; Steadman L; Dickson RB
    Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for c-Abl in c-myc regulation.
    Wong KK; Hardin JD; Boast S; Cooper CL; Merrell KT; Doyle TG; Goff SP; Calame KL
    Oncogene; 1995 Feb; 10(4):705-11. PubMed ID: 7862448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function.
    Dubois NC; Adolphe C; Ehninger A; Wang RA; Robertson EJ; Trumpp A
    Development; 2008 Aug; 135(14):2455-65. PubMed ID: 18550708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells].
    Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
    Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
    Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.